Effect of gestational diabetes mellitus on maternal and infant fatty acid metabolism

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000041239

Enrollment

Unknown

Registered

2020-12-22

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes

Interventions

gestational diabetes mellitus group vs. normal control group:Nil

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Women of Han nationality, 2. Subjects without other diseases during pregnancy (such as pregnancy induced hypertension, preeclampsia and other metabolic diseases), 3. Healthy newborns with single term delivery (gestational period: 37-42 weeks), 4. Volunteers.

Exclusion criteria

Exclusion criteria: 1. Subjects with abnormal thyroid function; 2. Subjects with pre pregnancy diabetes, hypertension, hyperlipidemia or other organ diseases; 3. Infants with congenital and hereditary diseases should be treated with hypoglycemic drugs.

Design outcomes

Primary

Measure	Time frame
Plasma fatty acids;	—

Countries

China

Contacts

Public ContactXie Lin

School of public health, Jilin University

xielin@jlu.edu.cn+86 431-85619455

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026